We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WYFI:NASDAQWhiteFiber, Inc. Analysis

Data as of 2026-08-31 - not real-time

$18.78

Latest Price

9/10Risk

Risk Level: High

Executive Summary

WhiteFiber, Inc. trades at $18.77, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Over a rolling month the price has lost 30.8%. Momentum indicators put RSI at 36.7 (approaching oversold) with MACD reading bearish. Price has been bracketed by support at $17.25 and resistance at $32.36.
Valuation screens as undervalued: a P/E of 36.4 sits in line with the sector average of 35.8. Analyst price targets sit 117.8% above the current price. Revenue is growing at 55.7% on a -47.7% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 141.5%, a beta of 4.45 and a maximum drawdown of 72.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.

Top Market Events

WhiteFiber targets full NC-1 billing by end-August as it expands multi-year cloud contracts, permanent financing and...WhiteFiber, Inc. Nasdaq: WYFI "WhiteFiber" or the "Company" , a provider of artificial intelligence "AI" infrastructure...WhiteFiber, Inc. NASDAQ: WYFI , a leading provider of AI infrastructure and HPC solutions, today announced that it will...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading below the 200-day average of 21.57
  • MACD momentum is negative
  • 30-day price change of -30.8%

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 36.4 versus sector average of 35.8
  • Trading below the 200-day average of 21.57
  • Analyst targets imply +117.8% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 36.4 versus sector average of 35.8
  • Negative profit margin of -47.7%
  • Analyst targets imply +117.8% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth55.70%
Profit Margin-47.66%
P/E Ratio36.4
ROE-13.73%
ROA-3.40%
Debt/Equity95.19
P/B Ratio1.5
Op. Cash Flow$141.6M
Free Cash Flow$-429604800
Industry P/E35.8

Technical Analysis

TrendNeutral
RSI36.7
Support$17.25
Resistance$32.36
MA 20$23.70
MA 50$28.51
MA 200$21.57
MACDBearish
VolumeIncreasing
Fear & Greed Index94.64

Valuation

Fair Value$82.55
Target Price$40.89
Upside/Downside117.78%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta4.45
Volatility141.45%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.